Disabling Staph's ATP Engine Makes It Vulnerable to the Body's Natural Antimicrobial Peptides
Inhibiting the ATP synthase in Staphylococcus aureus — even with resveratrol — sensitized it to killing by human defensins, LL-37, and histatin, boosting innate immune defense.
Quick Facts
What This Study Found
ATP synthase inactivation sensitized S. aureus to killing by hBD2, hBD4, LL-37, and histatin 5; resveratrol (an ATP synthase inhibitor) reproduced this sensitization.
Key Numbers
Increased susceptibility to 4/6 AMPs; resveratrol sensitized WT to hBD4; atpA mutant more susceptible to neutrophil killing
How They Did This
In vitro: S. aureus wild-type vs ATP synthase mutant (atpA) tested against six human AMPs (hBD1-4, LL-37, histatin 5); resveratrol treatment; neutrophil killing assays with and without oxidative burst inhibition.
Why This Research Matters
Instead of developing new antibiotics, this approach would make S. aureus infections treatable by the body's own immune peptides — a strategy resistant bacteria would find harder to counter.
The Bigger Picture
MRSA and drug-resistant Staph infections are a global crisis. Therapeutic strategies that boost the body's natural antimicrobial defenses rather than adding new antibiotics represent a paradigm shift.
What This Study Doesn't Tell Us
In vitro only; resveratrol concentrations needed may not be achievable in vivo; ATP synthase inhibition could affect host cells; mechanism of selectivity for some AMPs but not others unclear.
Questions This Raises
- ?Can ATP synthase inhibitors like resveratrol reach effective concentrations at infection sites?
- ?Would this approach work against MRSA strains in animal infection models?
- ?Why does ATP synthase protect against hBD4 but not hBD3?
Trust & Context
- Key Stat:
- Resveratrol sensitizes The dietary compound resveratrol inhibited S. aureus ATP synthase and sensitized bacteria to human β-defensin 4 killing
- Evidence Grade:
- Moderate — well-designed in vitro study with genetic and pharmacological confirmation, but no in vivo infection data.
- Study Age:
- Published in 2020; ATP synthase as an antibiotic target is a growing research area.
- Original Title:
- Inhibition of the ATP synthase sensitizes Staphylococcus aureus towards human antimicrobial peptides.
- Published In:
- Scientific reports, 10(1), 11391 (2020)
- Authors:
- Liu, Liping, Beck, Christian, Nøhr-Meldgaard, Katrine, Peschel, Andreas, Kretschmer, Dorothee, Ingmer, Hanne, Vestergaard, Martin
- Database ID:
- RPEP-04960
Evidence Hierarchy
Frequently Asked Questions
How does ATP synthase protect bacteria from immune peptides?
ATP synthase generates energy that bacteria may use to repair membrane damage caused by antimicrobial peptides. Without this energy, the bacteria can't fix the holes peptides punch in their membranes.
Could drinking resveratrol supplements help fight Staph infections?
The concentrations needed are likely much higher than dietary supplements provide. This is more likely to inform drug development than consumer supplement use.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04960APA
Liu, Liping; Beck, Christian; Nøhr-Meldgaard, Katrine; Peschel, Andreas; Kretschmer, Dorothee; Ingmer, Hanne; Vestergaard, Martin. (2020). Inhibition of the ATP synthase sensitizes Staphylococcus aureus towards human antimicrobial peptides.. Scientific reports, 10(1), 11391. https://doi.org/10.1038/s41598-020-68146-4
MLA
Liu, Liping, et al. "Inhibition of the ATP synthase sensitizes Staphylococcus aureus towards human antimicrobial peptides.." Scientific reports, 2020. https://doi.org/10.1038/s41598-020-68146-4
RethinkPeptides
RethinkPeptides Research Database. "Inhibition of the ATP synthase sensitizes Staphylococcus aur..." RPEP-04960. Retrieved from https://rethinkpeptides.com/research/liu-2020-inhibition-of-the-atp
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.